Your Primer to Healthcare Mergers and Acquisitions

Author: Alan J. Hymowitz

Market Trends
The Rise in Healthcare Investments: 8 Facts and Stats to Know

As the initial shock of the COVID-19 pandemic began to subside, investing in healthcare went in the opposite direction. We saw and continue to see private equity firms and search funds investing more and more money into healthcare, with no indication that this trend is slowing down.

What's fueling these investments? Where is the money going? How much money is being invested? Let's answer these and other questions about the increase in healthcare investments by looking at eight facts and statistics.

Read More
Exit Planning
Choosing a Buyer: Private Equity vs. Search Fund vs. Strategic

Once you've decided to sell your healthcare company, one of the biggest decisions you may need to make is which type of buyer you will choose. If your company attracts a variety of buyers, you're likely to have a choice between private equity (i.e., financial buyer), search fund, and/or strategic buyer. All generally have the same goals in mind, but approach deals in different ways. 

Read More
Healthcare Sectors, Market Trends
Mark Cuban Cost Plus Drug Company: How Will it Affect Retail Pharmacy?

About six months ago, the Cost Plus Drug Company, entrepreneur Mark Cuban's online pharmacy, officially launched. As of late, the pharmacy is receiving significant media attention, including a study published in the journal Annals of Internal Medicine which showed Medicare could have saved nearly $4 billion in 2020 by purchasing generic drugs at the same prices offered by Cost Plus. Cuban took to Twitter to share the results with and tag President Joe Biden and other elected officials.

Read More
Exit Planning
Selling a C Corporation: Key Tax Implications You Should Understand

Depending on your healthcare company's corporation type, there are different tax implications you will want to be aware of long before you are ready to sell your business. One type of company that brings with it tax implications that often catch owners off-guard or create challenges when owners are ready to pursue a transaction is C corporations (C-corp).

Read More
Healthcare Sectors, Valuation
Understanding and Valuing a Freestanding Emergency Department

Freestanding emergency departments (FSED) have seen substantial growth over the past two decades. Research published in the Western Journal of Emergency Medicine states that the National Emergency Department Inventory determined in 2001 that about 1% of all emergency departments (ED) in the United States were FSEDs. Fast forward to 2016 and the Medicare Payment Advisory Commission reported that FSEDs had accounted for 11% of all EDs nationwide. Grand View Research is projecting that the U.S. FSED market size, which was valued at around $3 billion in 2019, is expected to expand at a compound annual growth rate (CAGR) of around 5% from 2020-2027.

Read More
Healthcare Sectors, Market Trends, Valuation
Retail Pharmacy Update: Opportunities, Challenges, and Valuations

Prior to the pandemic, the retail pharmacy industry was experiencing significant disruption. We were witnessing a steady increase in transactions and consolidation, Amazon's entry into the market, significant changes to strategic alliances between major payers and pharmacy benefit managers (PBMs), and the introduction of a wide array of new technologies, just to name a few noteworthy trends and developments. It's safe to say that COVID-19 not only disrupted some of these disruptors, but it also brought with it new disruptors.

Read More
Market Trends
5 Reasons 2021 Will Be a Very Big Year for Healthcare Transactions

Each year typically brings at least some unforeseen developments that influence healthcare transactions. Oftentimes, these occurrences affect a single sector or just a few sectors. Rarely, if ever, is there an unexpected event that touches numerous marketplaces, let alone all of them, and does so in a dramatic way.

Read More
Healthcare Sectors, Market Trends
8 Pharmacy Trends From 2020 That Are Here To Stay

As we approach the end of year, it's a good time to look back and identify some of the more significant pharmaceutical developments from 2020 that are playing a role in influencing or reshaping the industry. Here are eight noteworthy trends that emerged or gained steam this year that are likely to follow us into 2021 and beyond.

Read More
Exit Planning, Market Trends
Completing an M&A Deal in the COVID-19 Era: What You Need to Know

Pre-COVID-19, a merger and acquisition (M&A) deal that followed an 80/10/10 structure was fairly common. In such in a transaction, up to 80% of a company's purchase price would be afforded to the seller as an upfront, cash proceed, at least 10% of the company's purchase price would be in the form of rollover equity, and at least 10% of the company's purchase price would be in the form of deferred proceeds (e.g., an earn-out or seller note).

Read More
Healthcare Sectors, Market Trends
7 Noteworthy Coronavirus News Developments for Pharmacies

While all of healthcare has been hit hard by the rapid spread of the novel coronavirus, some industries have been affected more than others. Much of the news has focused on the impact to those facilities providing care to clients and patients, such as nursing homes, senior living, hospitals, and urgent care centers, there's another industry that's been greatly impacted but is under the radar: pharmacy.

Read More
Healthcare Sectors
Fall of Diplomat Pharmacy: 10 Things That Went Wrong

In July 2015, Diplomat Pharmacy was the talk of the town. Momentum seemed like it was on the company's side, with Diplomat looking poised to be a major player for many years to come. But, as it is often said, "the higher they rise, the harder they fall." In December 2019, UnitedHealth Group's OptumRx agreed to acquire Diplomat for about $4 a share in cash. What caused this "All-American success story" to come up so short on expectations?

Read More
Healthcare Sectors
What I'm Listening for at the National Association of Specialty Pharmacy Meeting

What are the current developments concerning specialty pharmacies? Alan Hymowitz takes a closer look at five key areas.

Read More

Committed to Constant Improvement?

Subscribe to our bi-weekly newsletter – VERTESSPress

No Spam Ever. We Promise.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram